Abstract: A method and apparatus for non-invasive analysing the structure and chemical composition of bone tissue eliminating the influence of surrounding tissues, is provided. The method consists in using a system of at least four electrodes (1, 2, 3, 4, 5, 6, 7, 8) placed in electrical contact with tissues surrounding the analysed bone, preferably a long bone to establish screening potential distribution using screening electrodes (7, 8). Measuring current injecting electrodes (1, 2) are used to force the measuring current flow through the internal part of the analysed bone. At the same time the screening electrodes (7, 8) reduce the measuring current flow through the tissues surrounding the analysed bone almost to zero. Then measuring current and potential at the measuring current injecting electrodes (1, 2) as well as phase difference between potential at measuring current injecting electrodes (1, 2) and measuring current are measured.

Abstract: Described are methods for the parameter change of parameterized functions for technical devices by means of a data processing device comprising pointing means and a display on which a sliding bar with corresponding sliding element is shown for the parameter change.

Abstract: An apparatus comprises a cardiac signal sensing circuit, a heart sound sensing circuit, and a signal processing circuit. The cardiac signal sensing circuit is configured to sense a plurality of cardiac signals representative of electrical cardiac activity of a subject. The heart sound sensing circuit is configured to sense a plurality of unfiltered heart sound signals representative of intrinsic mechanical cardiac activity of the subject. The signal processing circuit is configured to: detect an R-wave in a sensed cardiac signal and initiate a measurement window in a time relationship to the detected R-wave; determine amplitude of an S1 heart sound using a heart sound signal sensed during the measurement window; trend S1 heart sound amplitudes determined for the plurality of the unfiltered heart sound signals; and generate an alert when the trended S1 heart sound amplitude decreases below a threshold amplitude value.

Abstract: An implantable medical device includes a sensing module configured to receive a cardiac electrical signal via electrodes carried by a medical electrical lead coupled to the implantable medical device and a control module configured to detect a lead issue. The sensing module is configured to produce cardiac sensed event signals and spike detect signals. The control module is configured to determine event intervals defined by consecutive ones of the received cardiac sensed event signals and the received spike detect signals and identify one or more received spike detect signals as lead issue spikes based on at least one of the determined event intervals.

Abstract: A TET system is operable to vary an amount of power transmitted from an external power supply to an implantable power unit in accordance with a monitored condition of the implantable power unit. The amount of power supplied to the implantable power unit for operating a pump, for example, can be varied in accordance with a cardiac cycle, so as to maintain the monitored condition in the power circuit within a desired range throughout the cardiac cycle.

Abstract: A medical lead with at least a distal portion thereof implantable in the brain of a patient is described, together with methods and systems for using the lead. The lead is provided with at least two sensing modalities (e.g., two or more sensing modalities for measurements of field potential measurements, neuronal single unit activity, neuronal multi unit activity, optical blood volume, optical blood oxygenation, voltammetry and rheoencephalography). Acquisition of measurements and the lead components and other components for accomplishing a measurement in each modality are also described as are various applications for the multimodal brain sensing lead.

Abstract: An encoding system for encoding an event time series, the system including an inter-arrival time computing device configured to compute an inter-arrival time between a plurality of input events and computes a sequence of events, a transformation device configured to transform the inter-arrival time between the plurality of input events into discrete time symbols, and a mapping device configured to map the input events and the discrete time symbols using a dictionary to output a time gram.

Abstract: Method and apparatus for diagnosis of conductor anomalies, such as partial conductor failures, in an implantable lead for an implantable medical device are disclosed. In various embodiments, small changes in the lead impedance are identified by the use of a small circuit element that is incorporated as part of the distal end of the implantable lead. In various embodiments, the small circuit element is electrically connected to a lead conductor and/or electrode of the implantable lead. Methods of diagnosing conductor anomalies in accordance with these embodiments generate measured values that depend only on the impedance of the conductors and electrodes of the lead, and not on the behavior of the conductor-tissue interface and other body tissues.

Abstract: An implantable medical device includes operational circuitry, such as a therapy circuit. The implantable medical device also includes a power source configured to deliver energy to the operational circuitry, and a deactivation element configured to disable the therapy circuit. A power manager is configured to detect an end-of-life condition of the power source and, in response to detecting the end-of-life condition, cause the deactivation element to reversibly disable the therapy circuit.

Abstract: Techniques for determining paced cardiac depolarization waveform morphological templates are described. For example, an implantable medical device (IMD) may sense a cardiac electrogram of a heart, identify cardiac depolarizations within the cardiac electrogram, and determine that the cardiac depolarizations are paced cardiac depolarizations resulting from delivery of a pacing pulse to the heart by another IMD without detecting the pacing pulse and without communicating with the other IMD. The IMD may identify paced cardiac depolarization waveforms of the paced cardiac depolarizations, determine a paced cardiac depolarization waveform morphological template based on the identified paced cardiac depolarization waveforms, determine a normal cardiac depolarization waveform morphological template based on the paced cardiac depolarization waveform morphological template, and compare the normal cardiac depolarization waveform morphological template to subsequent cardiac depolarization waveforms.

Abstract: A first entry is received at an event log interface. The event log interface is configured to store received entries in an event log. It is determined that there is not enough storage space to store the first entry in the event log. A second entry is identified. The second entry is the oldest entry in the event log based on when the second entry was written to the event log. It is determined that the second entry contains an indicator to preserve. A copy of the second entry is sent to the event log interface to be written to the event log. One or more entries are deleted from the event log. The one or more entries includes the second entry. The first entry is written to the event log. The copy of the second entry is written to the event log.

Abstract: Methods, systems, and devices for signal analysis in an implantable cardiac device such as an implantable cardioverter defibrillator. In illustrative examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. Analysis of the apparent width of detected events is used to determine whether overdetection is occurring. If overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data.

Abstract: A method of evaluating a portal dose image includes obtaining a template from a database, the template prescribing one or more evaluation criteria, receiving a first portal dose image, and using a processor to evaluate the first portal dose image based at least in part on the one or more evaluation criteria from the template. In some embodiments, a second image is automatically evaluated after the first image is evaluated. A system for evaluating a portal dose image includes a processor that is communicatively coupled to a database, the database having a template that prescribes one or more evaluation criteria, wherein the processor is configured to obtain the template from the database, receive a first portal dose image, and evaluate the first portal dose image based at least in part on the one or more evaluation criteria from the template.

Abstract: An implantable medical device capable of sensing cardiac signals and delivering cardiac electrical stimulation therapies is enabled to detect a short circuit of a medical electrical lead. A physiological signal correlated to a motion of a patient is sensed via a physiological sensor. If a lead monitoring condition is met based on the physiological signal, a cardiac signal is acquired and analyzed to detect an abnormality. The short circuit of the medical electrical lead is detected in response to detecting the abnormality.

Abstract: A sensor detects the rotation of a component (object) of a vehicle in a non-contact manner, and generates a differential signal according to the rotation. Two comparators have different hysteresis characteristics. At both edges of one signal that is an output of one of the comparators, if a signal of the other comparator is not at the same level, it is determined that a distance (gap) between an object and the sensor is within a predetermined range in which the differential signal is effective.

Abstract: A system is provided for generating electrical signals. The system comprises: an input configured to receive first values, the first values representing coordinates of a plurality of break points of a heart beat waveform, and further configured to output programming signals; a communication port configured to receive the programming signals from the control panel; a memory configured to store instructions and predetermined values; a processor configured to process the programming signals and predetermined values according to the instructions stored in the memory; and an output port configured to make the processed signals available to a system under test.

Abstract: A first entry is received at an event log interface. The event log interface is configured to store received entries in an event log. It is determined that there is not enough storage space to store the first entry in the event log. A second entry is identified. The second entry is the oldest entry in the event log based on when the second entry was written to the event log. It is determined that the second entry contains an indicator to preserve. A copy of the second entry is sent to the event log interface to be written to the event log. One or more entries are deleted from the event log. The one or more entries includes the second entry. The first entry is written to the event log. The copy of the second entry is written to the event log.

Abstract: Disclosed are an apparatus for detecting wrist steps and a method thereof, which can exactly detect a user wrist step based on a plurality of acceleration signals. The apparatus includes an acceleration sensor, a controller and a display unit. The acceleration sensor detects a plurality of acceleration signals corresponding to a plurality of axis directions. The controller detects a plurality of wrist step feature points corresponding to the plurality of acceleration signals, detects time periods between the plurality of wrist step feature points, selects any one acceleration signal among the plurality of acceleration signals based on a standard deviation of the time periods, and detects wrist steps corresponding to the selected acceleration signal. The display unit displays the wrist steps.

Abstract: A sensor system includes a sensor and a sensor electronics device. The sensor includes a plurality of electrodes. The sensor electronics device includes a connection detection device, a power source, and a delay circuit. The connection detection device determines if the sensor electronics device is connected to the sensor and transmits a connection signal. The delay circuit receives the connection signal, waits a preset hydration time, and couples the regulated voltage from the power source to an electrode in the sensor after the preset hydration time has elapsed. Alternatively, the sensor electronics device may include an electrical detection circuit and a microcontroller. The electrical detection circuit determines if the plurality of electrodes are hydrated and generates an interrupt if the electrodes are hydrated. A microcontroller receives the interrupt and transmits a signal representative of a voltage to an electrode of the plurality of electrodes.

Abstract: An interactive representation of electrostimulation electrodes or vectors can be provided, such as for configuring combinations of electrostimulation electrodes. In an example, electrodes or test parameters can be presented graphically or in a table. A user interface can be configured to receive user-input designating electrode combinations or vectors for test or for use in programming an implantable or ambulatory medical device. The interface can be used to indicate suggested electrode combinations or vectors in response to a first selection of an electrode. Tests can be performed on electrode combinations and vectors, and the results of the tests can be presented to a user using the interactive representation. In an example, test results can be analyzed by a processor and optionally used to program an implantable or ambulatory medical device.

Abstract: An image processing apparatus includes a request determining unit receiving an operation event indicating a request to use an image processing function and determining whether the request is from a guest user based on the received operation event; a guest login processing unit generating guest login information including a guest user identifier and access right information of the guest user if the request is from the guest user and sending a login request to request a login process for the guest user based on the guest login information; an access control unit disabling access control on the image processing function in response to the login request based on the access right information in the guest login information; and a usage history recording unit recording a usage history of the image processing function in association with the guest user based on the guest user identifier in the guest login information.

Abstract: A method and medical device for determining sensing vectors that includes sensing cardiac signals from a plurality of electrodes, the plurality of electrodes forming a plurality of sensing vectors, setting a blanking period and a blanking period adjustment window for the plurality of sensing vectors in response to the sensed cardiac signals, determining first signal differences during the blanking period adjustment window, and adjusting the blanking period in response to the determined first signal differences.

Abstract: Systems and methods for communicating between medical devices. In on example, a medical device comprises a communication module for communicating with an implantable leadless cardiac pacemaker through body tissue and a controller operatively coupled to the communications module. The controller may be configured to: identify intrinsic heartbeats; provide a blanking period after each occurrence of an intrinsic heartbeat; and communicate with the implantable leadless cardiac pacemaker via the communication module only during times between the blanking periods.

Abstract: A method, programmer for a neurostimulator, and neurostimulation kit are provided. The kit comprises a neurostimulator, and a plurality of elongated lead bodies configured for being coupled to the neurostimulator, each having a plurality of proximal contacts and a plurality of distal electrodes respectively electrically coupled to the proximal contacts, wherein an in-line connectivity between the electrodes and proximal contacts carried by the different lead bodies differs from each other. Electrical energy is conveyed between the electrodes of the selected lead body and the tissue, an electrical fingerprint is measured at the proximal contacts of the selected lead body in response to the conveyed electrical energy, and the selected lead body is identified based on the measured electrical fingerprint. These steps can be performed by the programmer.

Abstract: A neurostimulation system includes a neural stimulation lead having a proximal portion and a distal portion and including a plurality of electrodes along the distal portion. The plurality of electrodes are configured for positioning proximate a portion of the autonomic nervous system. A neural stimulation circuit, coupled to the plurality of electrodes, delivers neural stimulation pulses to the plurality of electrodes. A processor and controller is configured to control the neural stimulation circuit to deliver first neural stimulation pulses to each of a plurality of electrode configurations. Each electrode configuration includes one or more of the plurality of electrodes. The processor and controller is further configured to receive information related to motor fiber activity that is induced in response to delivery of the first neural stimulation pulses to each of the plurality of electrode configurations and to identify the electrode configurations that induce the motor fiber activity.

Abstract: In general, the invention is directed to a system with a fail-safe mode for remote programming of medical devices, such as implantable medical devices (IMDs). During a remote programming session, an adverse event, such as a programming session failure, may prevent proper completion of a programming or result in improper programming due to data corruption or other factors. If a programming session is not completed correctly, the IMD is susceptible to improper operation, possibly exposing a patient to delivery of unnecessary or inappropriate therapies. A fail-safe mode reduces the likelihood of improper operation following a programming session failure. The fail-safe mode defines one or more fail-safe operations designed to preserve proper operation of the IMD. In some embodiments, the fail-safe operations include notifying a person concerning the failure of the programming session, modifying programming parameters within the implantable medical device, and delivering a therapy to a patient.

Abstract: Methods and/or devices used in delivering cardiac resynchronization therapy based on a plurality of device parameters (e.g., A-V delay, V-V delay, etc.) are optimized by setting a device parameter based on selection data. The selection data may be acquired by acquiring temporal fiducial points (e.g., heart sounds) associated with at least a part of a systolic portion of at least one cardiac cycle and/or temporal fiducial points associated with at least a part of a diastolic portion of the at least one cardiac cycle for each of a plurality of electrode vector configurations, and extracting measurements from the intracardiac impedance signal acquired for each of a plurality of electrode vector configurations based on the temporal fiducial points. The acquired selection data may be scored and used to optimize the device parameter.

Abstract: The invention is related to a feeding tube (1, 11, 15) in particular for total parental nutrition and/or medicine dosing including at least one inner tubing (9), at least one lumen (2, 13), at least one sensing element, in particular an electrode (3), the sensing element being connected to at least one monitoring device by a wiring (4, 12, 17) for internal monitoring of a patient's vital functions. The wiring (4, 12, 17) is at least partially wounded in tight contact with a surface of the inner tubing (9). Wherein the inner tubing (9) is at least partially surrounded by an outer tubing (8) in order to cover the inner tubing (9) and/or the wiring (4, 12, 17).

Abstract: A fixation member component, for example, employed by a relatively compact implantable medical device, includes a plurality of fingers; each finger includes a first segment extending from a fixed end of the corresponding finger, and a second segment extending from the corresponding first segment to a free end of the corresponding finger. Each first segment is elastically deformable from a relaxed to an extended condition, and from the relaxed to a compressed condition, and includes a peripheral portion and a central cut-out portion, framed by the peripheral portion. In the compressed condition, a free tip of the cut-out portion of some or all of the fingers may lodge against opposing tissue surfaces, via a spring force of the compressed fingers. Each second segment and cut-out portion is preferably configured to prevent penetration thereof within tissue at the implant site.

Abstract: A fluid path set and method of use thereof is disclosed. The fluid path set includes a multi-patient fluid path section adapted for fluid connection to at least one pressurizing device, a per-patient fluid path section adapted for fluid connection with a patient, and a connector for removably and fluidly connecting the multi-patient fluid path section with the per-patient fluid path section. The connector includes a first connector member having an outer housing member and a first luer member recessed within the outer housing member, and a second connector member having a second threaded member and a second luer member recessed within the second threaded member. The first luer member and the second threaded member cooperate to securely and releasably connect the first connector member with the second connector member to establish removable fluid connection between the multi-patient fluid path section and the per-patient fluid path section.

Abstract: Systems and methods for treating cardiac arrhythmias are disclosed. In one embodiment, an SICD comprises two or more electrodes, a charge storage device, and a controller operatively coupled to two or more of the electrodes and the charge storage device. In some embodiments, the controller is configured to monitor cardiac activity of the heart of the patient, detect an occurrence of a cardiac arrhythmia based on the cardiac activity, and determine a type of the detected cardiac arrhythmia from two or more types of cardiac arrhythmias. If the determined type of cardiac arrhythmia is one of a first set of cardiac arrhythmia types, the controller sends an instruction for reception by an LCP to initiate the application of ATP therapy by the LCP. If the determined type of cardiac arrhythmia is not one of the first set cardiac arrhythmia types, the controller does not send the instruction.

Abstract: The present disclosure is directed to an electrogram summary. In various examples, a subset of cardiac episodes are selected and displayed based on a set of summary rules. The subset of cardiac episodes includes at least one episode from each of a plurality of episode categories with at least one cardiac episode. In some examples, the order in which the cardiac episodes selected are displayed is based on the set of summary rules. The electrogram summary may include images or information regarding each of the selected cardiac episodes.

Abstract: A method and apparatus for determining estimated remaining longevity for an implantable stimulator. A programmer processor is employed to acquire from the implantable stimulator a signal comprising data associated with the power source in the implantable stimulator and a date in which the stimulator was implanted. The programmer processor and the data are used to determine whether a pre-recommended replacement time threshold (pre-RRT) has been attained for replacing the implantable stimulator. The programmer processor is used to select an equation in which to calculate a recommended replacement time (RRT), the equation is selected in response to determining a time period that extends from the date in which the stimulator was implanted until a date in which the pre-RRT is attained.

Abstract: A patient suffering from congestive heart failure is at increased risk of cardiac arrhythmogenesis during sleep, particularly if experiencing central sleep apnea as a co-morbidity. Low intensity peripheral neurostimulation therapies that target imbalance of the autonomic nervous system have been shown to improve clinical outcomes. Thus, bi-directional autonomic regulation therapy is delivered to the cervical vagus nerve at an intensity that is insufficient to elicit pathological or acute physiological side effects and without the requirement of an enabling physiological feature or triggering physiological marker. The patient's physiology is monitored to identify periods of sleep. In one embodiment, upon sensing a condition indicative of tachyarrhythmia following a period of bradycardia, as naturally occurs during sleep, an enhanced “boost” dose of bi-directional neural stimulation intended to “break” the tachyarrhythmic condition is delivered.

Abstract: An implantable medical device detects conditions such as a lead failure which may result in oversensing a physiologic condition. In response, the IMD automatically adjusts sensing thresholds, such as the number of intervals to detection in order to mitigate the effect of oversensing in the delivery of extraneous therapy.

Abstract: A lead frame for attaching leads to a hermetic feedthrough includes a cross-member and a plurality of leads. Each of the leads has an elongate body extending from the cross-member in a direction substantially parallel with one another, and each lead includes at least one of a notch on an end thereof opposite to the cross-member or a hole proximate to the end.

Abstract: A vehicle assistance device for a driver includes a control unit for generating data that indicates information with respect to the temporal occurrence of an event along a route of a vehicle. A display unit displays a map of the route of the vehicle between a starting point and a destination point of the route. The control unit controls the display unit with data, wherein the control unit generates the data in such a way that the information characterizing the temporal occurrence of an event is displayed on the display unit along the map of the route as a function of the point-in-time of occurrence of the event.

Abstract: A method and apparatus for determining estimated remaining longevity for an implantable stimulator. The device employs pre-calculated numbers of days for various combinations conditions of device usage parameters to determine remaining device longevity based upon identified actual conditions of device usage and employs the determined longevity to change longevity indicator states in the device. While between longevity state changes, the device the identified conditions of device usage and adjusts the determined longevity if the conditions of use change significantly. The indicator states may correspond to one or more of Recommended Replacement Time (RRT), Elective Replacement Indicator (ERI) or End of Service (EOS).

Abstract: Impedance information of an implantable medical device is displayed. One or more impedance values are received over a period of time for a plurality of channels. The channels may each include an electrode contact on an implantable lead. A graph is displayed that illustrates a variation of the impedance values over at least a portion of the period of time for one or more of the channels. A visual landscape that is representative of the impedance values for the plurality of channels is also displayed.

Abstract: The present disclosure involves a method of facilitating visualization in a medical context. The method includes displaying a virtual reality representation of a medical device via a touch-sensitive user interface. The virtual reality representation of the medical device includes a movable and rotatable three-dimensional model of the medical device. The method includes displaying a virtual reality representation of an anatomical environment of a patient via a touch-sensitive user interface. The virtual reality representation of the anatomical environment is zoomable and scalable. The method includes customizing the virtual reality representation of the medical device. The method includes positioning the customized virtual reality representation of the medical device in an appropriate location of the virtual reality representation of the anatomical environment. The customizing and the positioning are performed in response to user input.

Abstract: A non-biological asynchronous neural network system comprising multiple neurons to receive respective input signals representing an input stimulus for the network, supply an output signal representing a spatio-temporal sequence of rhythmic electric pulses to an external system, wherein respective ones of the multiple neurons are connected using multiple mutually inhibitory links.

Abstract: The present disclosure describes an implantable medical device utilizing an event-triggered prognostic indicator. The disclosure describes techniques for prognostics and management of implantable medical systems to facilitate continuity of performance of sensing and therapy delivery functions by providing adequate response time to handle emerging issues prior to adverse clinical impacts. In accordance with the present disclosure, event-triggered prognostic indicators facilitate the identification of potential device conditions.

Abstract: Techniques for performing a lead integrity test in response to, e.g., during or after saturation of a sensed signal, e.g., a cardiac electrogram (EGM) signal, are described. A lead integrity test may comprise one or more impedance measurements for one or more leads. Possible causes of saturation of a sensed signal include lead conductor or connector issues, or other lead related conditions. A lead integrity test triggered in response to the saturation may be able to detect any lead related condition causing the saturation. A lead integrity test triggered in response to the saturation may advantageously be able to detect an intermittent lead related condition, due to the temporal proximity of the test to the saturation.

Abstract: Methods and systems for optimizing stimulation of a heart of a patient are disclosed. The method comprises: determining recommended pacing settings including recommended AV delays and/or recommended VV delays based on IEGM data. Further, at least one hemodynamical parameter is determined based on measured at least one hemodynamical signal. Reference pacing settings are determined including reference AV delays and/or reference VV delays based on said hemodynamical parameters. An AV delay correction value and a VV delay correction value are calculated as a difference between recommended AV and/or VV delays and reference AV and/or VV delays, respectively. The correction values are used for updating recommended AV and/or VV delays, respectively.

Abstract: An apparatus configured to be placed about an implantable medical device having a face with a geometric center offset from a center of a recharge coil of the device includes first and second opposing major exterior surfaces, and a continuous exterior side surface joining the first and second opposing major exterior surfaces. A cavity is defined between, and an opening is formed by, the first and second major surfaces and the continuous side surface. The opening is in communication with the cavity and is configured to allow the device to access the cavity. An asymmetric region, adjacent to the cavity, is formed between a portion of the first and second major surfaces and the continuous side surface. The asymmetric region is configured to shift the geometric center of the combined apparatus and device, when the device is received in the cavity, towards the center of the recharge coil.

Abstract: An exemplary method includes performing a capture threshold assessment using a bipolar electrode configuration, deciding if capture occurred for a maximum energy value of the capture threshold assessment and, if capture did not occur, then performing a lead impedance test for the lead associated with the bipolar electrode configuration. Such a test may aim to detect an insulation defect and/or a conductor defect. Other exemplary methods, devices, systems, etc., are also disclosed.

Abstract: An implantable cardioverter defibrillator (ICD) includes a communication interface operable to receive a communication signal from an external programmer. With the ICD not being in the presence of an MRI field generated by an MRI scanner, a communication signal is sent precharging a high energy storage capacitor before the patient undergoes the MRI scan. The signal also switches the ICD into an MRI mode which turns off the ICD's sensing functions detecting a dangerous ventricular arrhythmia. An operator monitors the patient's vital signs with sensors connected to the patient. If the patient does require the defibrillation shock, the operator sends a second communication signal delivering the defibrillation shock from the precharged high energy storage capacitor of the ICD. The patient can then be removed from the MRI scanner and the RF and gradient fields of the MRI scanner turned off.

Abstract: In some examples, a leadless pacing device (hereinafter, “LPD”) is configured for implantation in a ventricle of a heart of a patient, and is configured to switch between an atrio-ventricular synchronous pacing mode and an asynchronous ventricular pacing mode in response to detection of one or more sensing events, which may be, for example, undersensing events. In some examples, an LPD is configured to switch from a sensing without pacing mode to an atrio-ventricular synchronous pacing mode in response to determining, for a threshold number of cardiac cycles, a ventricular depolarization was not detected within a ventricular event detection window that begins at an atrial activation event.

Abstract: Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia. The LPD may receive communication from the SICD requesting the LPD deliver anti-tachycardia pacing to the heart and determine, based on a second electrical signal from the heart sensed by the LPD, whether to deliver anti-tachycardia pacing (ATP) to the heart. In this manner, the SICD and LPD may communicate to coordinate ATP and/or cardioversion/defibrillation therapy. In another example, the LPD may be configured to deliver post-shock pacing after detecting delivery of anti-tachyarrhythmia shock therapy.

Abstract: An endoscopic procedure for the parasympathetic and sympathetic denervation of the nerves of the ovaries and uterus for management of endocrine dysphoric disorders. The tissues of selected inferior mesenteric and pelvic nerves are heated via introduction of radiofrequency energy at sufficient power and time to induce complete or partial nerve blockade while leaving the supporting tissue structurally intact. In some embodiments, the suspensory ligament of the ovary, the ovarian ligament, and/or the uterosacral ligament are heated to a range of 45° C. to 65° C. for a period of about 5 seconds to about 60 seconds.